A Double-Blind, Randomized, Dose-Controlled Study to Evaluate Pharmacodynamic Properties of Four Oral Doses of Dienogest (DNG) in 100 Healthy Young Female Volunteers Over a Period of Two Cycles up to a Maximum of 72 Days.
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2015
At a glance
- Drugs Dienogest (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Bayer
- 23 Sep 2009 Actual patient number (199) added as reported by ClinicalTrials.gov.
- 23 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.